Hepatocellular carcinoma (HCC) remains one of the most common and deadly forms of liver cancer globally. The complexity of HCC, combined with late-stage diagnosis in many patients, creates significant challenges in effective treatment. Over the past decade, the hepatocellular carcinoma drugs has undergone rapid transformation, influenced by advances in targeted therapies, immunotherap... https://hallbook.com.br/blogs/749060/Emerging-Trends-and-Innovations-in-Hepatocellular-Carcinoma-Drugs